126 related articles for article (PubMed ID: 28076475)
1. EXPRESSION OF E-CADHERIN AND WNT PATHWAY PROTEINS BETACATENIN, APC, TCF-4 AND SURVIVIN IN GASTRIC ADENOCARCINOMA: CLINICAL AND PATHOLOGICAL IMPLICATION.
Lins RR; Oshima CT; Oliveira LA; Silva MS; Mader AM; Waisberg J
Arq Bras Cir Dig; 2016; 29(4):227-231. PubMed ID: 28076475
[TBL] [Abstract][Full Text] [Related]
2. Expression of the E-cadherin/β-catenin/tcf-4 pathway in gastric diseases with relation to Helicobacter pylori infection: clinical and pathological implications.
Yu XW; Xu Q; Xu Y; Gong YH; Yuan Y
Asian Pac J Cancer Prev; 2014; 15(1):215-20. PubMed ID: 24528029
[TBL] [Abstract][Full Text] [Related]
3. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.
Ayed-Guerfali DB; Hassairi B; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2014 Mar; 35(3):1775-83. PubMed ID: 24197976
[TBL] [Abstract][Full Text] [Related]
4. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
5. Calcium, calcium-sensing receptor and colon cancer.
Whitfield JF
Cancer Lett; 2009 Mar; 275(1):9-16. PubMed ID: 18725175
[TBL] [Abstract][Full Text] [Related]
6. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Tcf-4, MMP7 and Survivin in Colorectal Cancer and Its Clinical Significance].
Ou YR; Jing GY; Wu Q; Gao S; Cheng ZN; Dong Xiu-qin
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 46(4):554-9. PubMed ID: 26480657
[TBL] [Abstract][Full Text] [Related]
8. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
[TBL] [Abstract][Full Text] [Related]
10. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma.
Zhou Y; Lan J; Wang W; Shi Q; Lan Y; Cheng Z; Guan H
J Mol Histol; 2013 Oct; 44(5):555-63. PubMed ID: 23504200
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
12. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q
Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026
[TBL] [Abstract][Full Text] [Related]
13. FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer.
Qin S; Zhang Z; Li J; Zang L
Oncol Rep; 2014 May; 31(5):2351-7. PubMed ID: 24676361
[TBL] [Abstract][Full Text] [Related]
14. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
Huang X; Guo B
Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
16. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
17. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
19. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions.
Huang Z; Zhang M; Burton SD; Katsakhyan LN; Ji H
ACS Chem Biol; 2014 Jan; 9(1):193-201. PubMed ID: 24191653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
